Tag: documents

OSE Immunotherapeutics met à jour l’information sur les procédures en cours

HOUSTON, July 01, 2025 (GLOBE NEWSWIRE) -- APA Corporation (Nasdaq: APA) today released its sustainability publications highlighting progress in environmental stewardship, social responsibility and corporate governance throughout 2024. This year, APA simplified its reporting into two complementary documents. Our Approach to Sustainability details the ongoing sustainability programs and initiatives. The 2025 Sustainability Progress Report contains progress on 2024 goals, yearly highlights, key performance data and new goals for 2025. To explore the publications, visit https://apacorp.com/sustainability.

SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has entered into a placement agency agreement for the purchase and sale of up to 800,000 shares of the Company’s Series H Convertible Preferred Stock (“Preferred Stock”), no par value, and Warrants to purchase up to an additional 800,000 shares of Preferred Stock of the Company at an exercise price of $25.00 per share (the “Warrants”). The combined public Offering price of each share of Preferred Stock together with an accompanying Warrant is $25.00 (the “Offering”). The Preferred Stock is convertible into the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price of $2.50 per share. The closing of the Offering is expected to occur on or about July 2, 2025, subject to the satisfaction of customary closing conditions.

Combined Company Expected to be Listed on NASDAQ Global Market

TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Purpose Investments Inc. is pleased to announce the 2025 second quarter distributions for Purpose Specialty Lending Trust.